Market Analysis on Cell & Gene Therapy Manufacturing Services Industry – Insights for Corporate Strategy and R&D
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Cell & Gene Therapy Manufacturing Services Market from 2024 to 2025?
The market size for manufacturing services in cell & gene therapy has witnessed remarkable growth in the last few years. Its expansion is projected to surge from $8.15 billion in 2024 to reach $9.46 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 16.1%. The historical growth of this market has been propelled by factors such as elevated investments in Research & Development, regulatory backing and frameworks, a rising pipeline for cell & gene therapies, collaborations and partnerships in the industry, and an enhancing worldwide demand for personalized medicine.
What Is the Projected Market Size of the Cell & Gene Therapy Manufacturing Services Market?
In the coming years, the market size for cell and gene therapy manufacturing services is projected to experience a significant increase. It’s predicted to reach $17.97 billion in 2029, recording a compound annual growth rate (CAGR) of 17.4%. The expected surge during the forecast period can be credited to the maturation and commercialization of the market, global expansion of biopharmaceutical manufacturing, increased outsourcing activities by pharmaceutical companies, advancements in automation and robotics, and the rise of new therapeutic models. Major trends expected during the forecast period include an increase in demand for energy efficiency, innovative materials, and technologies, compact and modular designs, transportation electrification, and a strong focus on safety and reliability.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10035&type=smp
Who are the Major Competitors in the Cell & Gene Therapy Manufacturing Services Market Outlook?
Major companies operating in the cell & gene therapy manufacturing services market include Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories International Inc., Lonza Group AG, Catalent Inc., WuXi AppTec, Takara Bio Inc., Nikon Corporation, Fujifilm Holdings Corporation, F. Hoffmann-La Roche Ltd, Oxford Biomedica plc, CGT Catapult, bluebird bio Inc., Boehringer Ingelheim International GmbH, Innovative Cellular Therapeutics Co. Ltd., Samsung Biologics Co. Ltd., Novartis International AG, Pfizer Inc., Brammer Bio, AGC Biologics, Cognate BioServices Inc., Paragon Bioservices Inc., Merck KGaA operating as MilliporeSigma, Sarepta Therapeutics Inc., Spark Therapeutics Inc., Orchard Therapeutics plc, Precision BioSciences Inc., PCT a Hitachi Group Company, Aldevron LLC, BioNTech SE
What Is Fueling Growth in the Cell & Gene Therapy Manufacturing Services Market?
The cell and gene therapy manufacturing services market is projected to expand due to the high prevalence of cancer and other targeted diseases. Cancer, a severe condition where body cells multiply rapidly and uncontrollably, leads to irregular growth. As promising new alternatives to tackle the growing cancer issue, cell and gene therapies are emerging, thereby fuelling the need for innovative and effective treatment options. For instance, the American Cancer Society, a non-profit cancer advocacy organization based in the US, reported in January 2023 that cancer cases surged from 1,898,160 in 2021 to 1,958,310 in 2023, reflecting a 3.16% increase. Thus, the high prevalence of cancer and other target diseases continues to stimulate the cell and gene therapy manufacturing services market’s progress.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=10035&type=smp
Which Cell & Gene Therapy Manufacturing Services Market Segments Are Growing the Fastest?
The cell & gene therapy manufacturing services market covered in this report is segmented –
1) By Type: Gene Therapy, Cell Therapy
2) By Indication: Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Oncology Diseases
3) By Application: Commercial Manufacturing, Clinical Manufacturing
4) By End-user: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users
Subsegments:
1) By Gene Therapy: Viral Vector Manufacturing, Plasmid DNA Production, Gene Editing Services, Formulation And Fill-Finish Services
2) By Cell Therapy: Cell Sourcing And Banking, Cell Processing And Expansion, Quality Control And Testing Services, Cryopreservation And Storage Services
Which Industry Trends Are Shaping the Future of the Cell & Gene Therapy Manufacturing Services Market?
The emergence of technological innovations is a notable trend in the cell and gene therapy manufacturing services market. Major players in this market are leveraging new technologies to maintain their competitive edge. For example, in October 2022, Charles River Laboratories International Inc.- a US-based pharmaceutical company with specialties in services such as preclinical and clinical laboratory, gene therapy, and cell therapy–unveiled the navigation Vector Platform (navigation). This tool simplifies the path toward GMP Adeno-Associated Virus (AAV) vector manufacturing without the need for extensive process development. In comparison to conventional manufacturing procedures, the navigation platform can reduce a program’s lead time to GMP by 55% for those conducting research on viral vector gene therapy. The navigation method used by Charles River is anchored on a unique, highly productive HEK293 suspension cell line that can be expanded and serotyped according to clients’ requirements.
Access The Full Report Here:
Which Countries Are Leading the Cell & Gene Therapy Manufacturing Services Market?
North America was the largest region in the cell and gene therapy manufacturing services market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global cell & gene therapy manufacturing services market report forecast period. The regions covered in the cell & gene therapy manufacturing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10035
This Report Delivers Insight On:
1. How big is the cell & gene therapy manufacturing services market, and how is it changing globally?
2. Who are the major companies in the cell & gene therapy manufacturing services market, and how are they performing?
3. What are the key opportunities and risks in the cell & gene therapy manufacturing services market right now?
4. Which products or customer segments are growing the most in the cell & gene therapy manufacturing services market?
5. What factors are helping or slowing down the growth of the cell & gene therapy manufacturing services market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
